"GIANT" macronodular adrenal hyperplasia causing Cushing's syndrome: case report and review of the literature on a clinical distinction of adrenocortical nodular pathology associated with hypercortisolism.
Cushing's syndrome (CS) may be sustained by a nodular adrenocortical pathology (NAP) in addition to hyperplastic or neoplastic lesions of adrenal glands. NAP, in turn, may be represented by macronodular (MACRO) or micronodular (MICRO) manifestations. There is debate as to whether the MACRO-NAP and MICRO-NAP represent an expression of the same disorder or relate to distinguishable anatomo-clinical entities. A case of CS sustained by a "giant" MACRO-NAP forced use to review the literature and to analyze the morpho-clinical findings from a statistical viewpoint. Testing procedures were able to significantly dissect some clinical, pathological and hormonal characteristics. The statistical probation clearly indicated that MACRO-NAP and MICRO-NAP causing CS are nosologic entities that can be clinically differentiated via their phenotypic symptomatology.
Cugini
P
P
Endocrine Pathophysiology, University of Rome, Italy.
Battisti
P
P
Di Palma
L
L
Sepe
M
M
Kawasaki
T
T
Uezono
K
K
Sasaki
H
H
D000302:Adrenal Cortex / Q000473:pathology / Q000503:physiopathology; D000311:Adrenal Glands / Q000473:pathology*; D000324:Adrenocorticotropic Hormone / Q000378:metabolism; D000328:Adult; D002467:Cell Nucleus / Q000473:pathology; D003480:Cushing Syndrome / Q000209:etiology* / Q000473:pathology / Q000503:physiopathology; D003593:Cytoplasm / Q000473:pathology; D006801:Humans; D006965:Hyperplasia; D008297:Male; D010902:Pituitary Gland / Q000473:pathology
D000324:Adrenocorticotropic Hormone